Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
35.23 USD | 0.00% | +7.80% | -14.41% |
May. 23 | Arvinas, Inc. Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Congress | CI |
May. 16 | Sector Update: Health Care Stocks Steady Premarket Thursday | MT |
Evolution of the average Target Price on Arvinas, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Arvinas, Inc.
Oppenheimer | |
HC Wainwright | |
Wedbush | |
Barclays | |
BMO Capital | |
Citigroup | |
Wells Fargo Securities | |
Jefferies & Co. | |
Guggenheim | |
Morgan Stanley | |
UBS | |
Stifel Nicolaus | |
Credit Suisse | |
Cantor Fitzgerald | |
Truist Securities | |
Piper Sandler | |
SVB Securities LLC | |
Goldman Sachs | |
Cowen | |
SVB Leerink | |
BofA Securities | |
Roth Capital Partners |
EPS Revisions
- Stock Market
- Equities
- ARVN Stock
- Consensus Arvinas, Inc.